A detailed history of Wells Fargo & Company transactions in Biogen Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 206,470 shares of BIIB stock, worth $32.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
206,470
Previous 247,760 16.67%
Holding current value
$32.2 Million
Previous $57.4 Million 30.32%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $7.81 Million - $9.78 Million
-41,290 Reduced 16.67%
206,470 $40 Million
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $5.08 Million - $6.32 Million
26,684 Added 12.07%
247,760 $57.4 Million
Q1 2024

May 10, 2024

SELL
$212.02 - $267.71 $2.2 Million - $2.78 Million
-10,375 Reduced 4.48%
221,076 $47.7 Million
Q4 2023

Feb 09, 2024

BUY
$222.59 - $267.94 $3.73 Million - $4.5 Million
16,778 Added 7.82%
231,451 $59.9 Million
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $8.9 Million - $10.1 Million
-35,155 Reduced 14.07%
214,673 $55.2 Million
Q2 2023

Aug 15, 2023

SELL
$275.25 - $318.06 $1.43 Million - $1.65 Million
-5,194 Reduced 2.04%
249,828 $71.2 Million
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $2.84 Million - $3.24 Million
-11,086 Reduced 4.17%
255,022 $70.9 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $13.3 Million - $16.2 Million
-52,870 Reduced 16.57%
266,108 $73.7 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $7.81 Million - $10.8 Million
-40,101 Reduced 11.17%
318,978 $85.2 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $15.1 Million - $18 Million
-80,651 Reduced 18.34%
359,079 $73.2 Million
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $7.51 Million - $9.46 Million
38,751 Added 9.66%
439,730 $92.6 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $38.6 Million - $49.7 Million
-172,597 Reduced 30.09%
400,979 $96.2 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $6.77 Million - $8.84 Million
23,940 Added 4.36%
573,576 $162 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $8.05 Million - $12.9 Million
-31,100 Reduced 5.36%
549,636 $190 Million
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $4.36 Million - $5.11 Million
-17,943 Reduced 3.0%
580,736 $162 Million
Q4 2020

Feb 09, 2021

SELL
$236.26 - $355.63 $36.3 Million - $54.7 Million
-153,694 Reduced 20.43%
598,679 $147 Million
Q3 2020

Nov 05, 2020

BUY
$264.77 - $305.71 $2.03 Million - $2.34 Million
7,649 Added 1.03%
752,373 $213 Million
Q2 2020

Aug 13, 2020

BUY
$258.66 - $342.55 $10.9 Million - $14.5 Million
42,187 Added 6.0%
744,724 $199 Million
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $189 Million - $240 Million
702,537 New
702,537 $222 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.